Abstract Details

Title NT-3 Gene Therapy Improves Compound Muscle Action Potential (CMAP) and Function in Mouse Model for Charcot-Marie-Tooth (CMT) Neuropathy

Topic Neurogenetics and Gene Therapy

Presentation(s) (-)

Poster/Presentation
Number 005

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Zarife Sahenk, MD, PhD, FAAN (The Research Institute at Nationwide Childrens.org)	Dr. Sahenk has nothing to disclose.
Gloria Galloway, MD, FAAN	No disclosure on file
Christopher Edwards (The Research Institute At Nationwide Children)	No disclosure on file
John W. Cochran, MD	No disclosure on file

��ɫ��